Fibromyalgia Treatment Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- AbbVie Inc.
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline plc
- Aptinyx Inc.
- Tonix Pharmaceuticals Holding Corp.
- Virios Therapeutics
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of fibromyalgia treatment is evaluated at USD 3.31 billion.
The global fibromyalgia treatment market size was worth more than USD 3.2 billion in 2025 and is poised to witness a CAGR of over 3.9%, crossing USD 4.69 billion revenue by 2035.
The North America fibromyalgia treatment market will hold over 42.9% share by 2035, driven by increasing prevalence and rising awareness of fibromyalgia.
Key players in the market include Pfizer Inc., AbbVie Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Aptinyx Inc., Tonix Pharmaceuticals Holding Corp., Virios Therapeutics.
